More about

Pulmonary Vein Isolation

News
March 31, 2025
3 min read
Save

Lifestyle changes plus drug therapy inferior to catheter ablation in AF, obesity

CHICAGO — For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various benefits but was inferior to catheter ablation for preventing recurrent AF, researchers reported.

News
October 16, 2024
3 min read
Save

Q&A: Importance of advanced EP training to deliver effective, durable AF ablation

Atrial fibrillation is a complex disease with ever-increasing treatment options, such as ablation, and advanced electrophysiology fellowship training is key to improving long-term outcomes, according to a new consensus statement.

News
October 02, 2024
3 min read
Save

AHA announces late-breaking lineup to be presented at 2024 Scientific Sessions

The American Heart Association Scientific Sessions will be held in-person only in Chicago from Nov. 16 to 18 and will feature eight late-breaking science sessions during the 3-day meeting.

News
September 06, 2024
2 min read
Save

Pulmonary vein isolation benefits patients with atrial fibrillation vs. sham procedure

Pulmonary vein isolation was associated with genuine improvements in patients with atrial fibrillation at 6 months that cannot be attributed to a placebo effect, researchers reported at the European Society of Cardiology Congress.

News
May 21, 2024
2 min read
Save

AI-guided cardiac ablation improves 1-year outcomes in persistent atrial fibrillation

Tailored ablation guided by AI was linked to better 1-year outcomes than pulmonary vein isolation alone for patients with persistent atrial fibrillation, according to the results of the TAILORED-AF trial presented at Heart Rhythm 2024.

News
May 21, 2024
2 min read
Save

Pulsed field ablation catheter tied to favorable 30-day safety in real-world AF cohort

In a real-world registry of patients with atrial fibrillation treated with a pulsed field ablation catheter, the system was associated with favorable 30-day outcomes, researchers reported at Heart Rhythm 2024.

News
January 31, 2024
1 min read
Save

FDA approves second pulsed field ablation system to treat atrial fibrillation

The FDA approved a second pulsed field ablation system for the treatment of adults with drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.

News
December 15, 2023
1 min read
Save

FDA approves first pulsed field AF ablation system

Medtronic announced the FDA approved its pulsed field ablation system for treatment of both paroxysmal and persistent atrial fibrillation via pulmonary vein isolation.

News
October 03, 2023
2 min read
Save

Four PVI techniques conferred similar efficacy in treating persistent AF

Ostial and antral pulmonary vein isolation, ablation plus posterior wall isolation and cryoablation all demonstrated comparable success in treating persistent atrial fibrillation, according to a post hoc analysis of the DECAAF II trial.

News
August 16, 2023
1 min read
Save

FDA clears AI algorithms to gauge success of complex arrhythmia ablation

CathVision announced the FDA clearance and commercial availability of two algorithms as part of its artificial intelligence-powered EP recording system for ECG interpretation.

View more